Ingrid Jyssum

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study

Ingrid Jyssum · Duo Research Archive (University of Oslo) · 2021 · 150 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

Immunogenicity and Safety of Standard and <scp>Third‐Dose SARS</scp>–<scp>CoV</scp>‐2 Vaccination in Patients Receiving Immunosuppressive Therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter et al. · Arthritis & Rheumatology · 2022 · 65 citations · Full text

Medicine, Immunology, Clinical Immunology +16

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter et al. · RMD Open · 2022 · 32 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases

Ingrid Jyssum, Johanna Elin Gehin, Joseph Sexton et al. · Lara D. Veeken · 2023 · 28 citations · Full text

Medicine, Immunology, Pharmacology +17

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

K. H. Bjørlykke, Hilde S Ørbo, Anne Therese Tveter et al. · The Lancet Rheumatology · 2022 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14